SCHEMBL1012959

SCHEMBL1012959

C1=CCSCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16398132 0.84
SCHEMBL3439955 0.81
SCHEMBL16094855 0.80
SCHEMBL16094969 0.78
SCHEMBL16094968 0.78
SCHEMBL622521 0.71
SCHEMBL1823248 0.70
SCHEMBL1275816 0.69
SCHEMBL16397899 0.69
SCHEMBL16095276 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 389 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1542692-B1 AMINOPYRIMIDINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AMGEN INC (US) 2011-01-05 EP claimed
EP-2270006-A1 Pyridazine derivatives useful as vanilloid receptor ligands Amgen, Inc (US) 2011-01-05 EP claimed
US-7524874-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2009-04-28 US claimed
US-7439360-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2008-10-21 US claimed
US-7396831-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2008-07-08 US claimed
US-7390907-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2008-06-24 US claimed
US-7332511-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2008-02-19 US claimed
EP-1780196-A2 Pyridine derivatives for use as vanilloid receptor ligands Amgen, Inc (US) 2007-05-02 EP claimed
US-20070093455-A1 10-substituted tetracyclines and methods of use thereof PARATEK PHARMACEUTICALS, INC. 2007-04-26 US claimed
US-7148221-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2006-12-12 US claimed
WO-2003049702-A2 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2003-06-19 WO claimed
CN-1056612-C Process for epoxidation of prochiral olefins, catalyst for use in the process SMITHKLINE BEECHAM PLC (GB) 2000-09-20 CN claimed
US-5916975-A Process for epoxidising prochiral olefins and a catalyst therefor and intermediates for making the catalyst SMITHKLINE BEECHAM P.L.C. (GB) 1999-06-29 US claimed
CN-1043425-C Novel compounds and process SMITHKLINE BEECHAM PLC (GB) 1999-05-19 CN claimed
US-5616750-A Compounds and process SMITHKLINE BEECHAM PLC (GB) 1997-04-01 US claimed
CN-1145623-A Process for epoxidation of prochiral olefins, catalyst for use in the process and intermediates for making the catalyst SMITHKLINE BEECHAM PLC (GB) 1997-03-19 CN claimed
EP-0741731-A1 PROCESS FOR EPOXIDISING PROCHIRAL OLEFINS AND A CATALYST THEREFOR AND INTERMEDIATES FOR MAKING THE CATALYST SMITHKLINE BEECHAM PLC (GB) 1996-11-13 EP claimed
EP-0655950-B1 CHIRAL CATALYSTS AND EPOXIDATION REACTIONS CATALYZED THEREBY SMITHKLINE BEECHAM PLC (GB) 1996-10-23 EP claimed
WO-1995021172-A1 PROCESS FOR EPOXIDISING PROCHIRAL OLEFINS AND A CATALYST THEREFOR AND INTERMEDIATES FOR MAKING THE CATALYST SMITHKLINE BEECHAM P.L.C. (GB) 1995-08-10 WO claimed
CN-1098415-A Novel compounds and method for making thereof SMITHKLINE BEECHAM PLC (GB) 1995-02-08 CN claimed